Teva Pharmaceutical Finance IV B.V., founded in 2016 and based in the Netherlands, is a subsidiary of Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company committed to improving health through innovative medicines and generic drugs. The company primarily focuses on the issuance of debt securities to support the financing needs of its parent organization's operations and strategic initiatives.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TEVA 1.00% 2025-07-28 CHFTeva Pharmaceutical Finance IV B.V. | Curaçao | 2025-07-28 | 1.000 | 0.00 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Teva Pharmaceutical Finance IV B.V. began its bond issuance program shortly after its establishment, with significant issuances such as a €1.5 billion bond in 2017, aimed at refinancing existing debt and strengthening its financial position. The issuer currently offers bonds with varying maturities, featuring competitive yields compared to industry averages. In recent developments, the company announced plans to restructure its debt portfolio, which may impact future bond offerings, making it an important player in the corporate bond market amid ongoing strategic transitions.